BioSpace News Archive

Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine and artificial intelligence -enabled digital pathology solutions for metabolic dysfunction-associated steatohepatitis, previously known as nonalcoholic steatohepatitis clinical trials.

Harmony Biosciences Holdings, Inc. today announced the appointment of Peter Anastasiou to the Company’s Board of Directors.

Medidata, a Dassault Systèmes company and leading provider of clinical trial solutions to the life sciences industry, announced new experiences for enhancing and streamlining clinical data workflows: Clinical Data Studio and Health Record Connect.

Viridian Therapeutics, Inc. today announced that senior management will participate in a fireside chat at the Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 4:00 p.m. GMT in London, UK.

Bicara Therapeutics today announced that company leadership will present at two upcoming investor conferences in November.

ENDRA Life Sciences Inc., a pioneer of Thermo Acoustic Enhanced UltraSound, announces the issuance of three new patents, including one in the U.S. and two in China.

MEI Pharma, Inc. today announced it will participate in the Stifel 2023 Healthcare Conference.

BioStem Technologies Inc. announced that the Centers for Medicare and Medicaid Services has published a new Q code, Q4279 for VENDAJE AC® pursuant to its application for Healthcare Common Procedure Coding System “Q” codes.

Arthrosi Therapeutics, Inc. today announced new clinical data from its phase 2 AR882-203 study in patients with tophaceous gout.

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM”) today announced encouraging translational data from an ongoing Phase 2 clinical trial utilizing AIM’s drug Ampligen® in patients with platinum-sensitive advanced recurrent ovarian cancer.